Acute Lymphoblastic Leukemia | NEJM
SciELO - Brasil - Acute lymphoblastic leukemia in children and adolescents: prognostic factors and analysis of survival Acute lymphoblastic leukemia in children and adolescents: prognostic factors and analysis of survival
Single‑cell RNA sequencing of t(8;21) acute myeloid leukemia for risk prediction
Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study | Leukemia
First Randomized Trial to Show Benefit of Tyrosine Kinase Inhibitor in Newly Diagnosed Acute Myeloid Leukemia - The ASCO Post
Blinatumomab Effective for Children with Relapsed Leukemia - NCI
The Expression Pattern of the Pre-B Cell Receptor Components Correlates with Cellular Stage and Clinical Outcome in Acute Lymphoblastic Leukemia | PLOS ONE
Kaplan–Meier Estimates of Event-free and Overall Survival among... | Download Scientific Diagram
Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children's Oncology Group phase III study AALL0433 | Haematologica
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531 | Journal of Clinical Oncology
View Image
Cancers | Free Full-Text | Outcome of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia before Second-Generation FLT3 Tyrosine Kinase Inhibitors: A Toulouse–Bordeaux DATAML Registry Study
Treatment of Acute Lymphoblastic Leukemia -- 30 Years' Experience at St. Jude Children's Research Hospital | NEJM
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer | NEJM
Frontiers | Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study
The Kaplan–Meier analysis of 5-year event-free survival and overall... | Download Scientific Diagram
Kaplan-Meier overall survival and event free survival curves of acute... | Download Scientific Diagram
Pharmacogenetic Analysis of Pediatric Patients with Acute Lymphoblastic Leukemia: A Possible Association between Survival Rate and ITPA Polymorphism | PLOS ONE
ASH 2022: FLAG-Ida Combined with Gemtuzumab Ozogamicin (GO) Improves Event Free Survival in Younger Patients with Newly Diagnosed Acute Myeloid Leukaemia (AML) and Shows an Overall Survival Benefit in NPM1 and FLT3
Interpretation of clinical endpoints in trials of acute myeloid leukemia - ScienceDirect
Treatment outcomes of pediatric acute myeloid leukemia: a retrospective analysis from 1996 to 2019 in Taiwan | Scientific Reports
A) Overall survival, (B) relapse-free survival, and (C) event-free... | Download Scientific Diagram
Enrolling children with acute lymphoblastic leukaemia on a clinical trial improves event-free survival: a population-based study | British Journal of Cancer
